Autoantibody formation and immune complex formation are important mediators in lupus pathogenesis, but an important role of the type I interferon (IFN) pathway has been identified in SLE patients and mouse models of lupus. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.